mail
versión imprimible
 
 

7th Oncolytic Virotherapy Summit 2022

Evvnt Promotion / evvnt
-
06.12.2022 - 08.12.2022  Hyatt Regency Boston, 1 Avenue de Lafayette, 02111 Boston, USA
Time: 8:00 am to 4:00 pm
 
Temas de la conferencia
2021 was a landmark year for clinical readouts within the oncolytic virotherapy field, and now OV developers are poised and ready at the cusp of something remarkable and this promising therapeutic is set to be a critical modality within cancer immunotherapy. With rapid advances in this compelling therapeutic, the Oncolytic Virotherapy Summit returns this December 2022 for its 7th edition.
La Sociedad Científica
Hanson Wade
Observaciones
Speakers: Antonio Chiocca, Chairman, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Barbara Haertl, Associate Vice President, Manufacturing Operations, Calidi Biotherapeutics
 

Información e inscripción:

https://go.evvnt.com/1259262-2?pid=4832
Ms. Stephanie Nketia
 
Categorías
Salud Pública, Servicios de salud
Idioma
Inglés
Cuota del Congreso
USD 2599.00 - USD 4897.00
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

Hilfswerk AustriaCharité International AcademyÖsterreichische Gesellschaft für Public HealthEuropean Public Health Association (EUPHA)European Health Forum GasteinAlumni Club Medizinische Universität WienÄrzte der WeltAGEM - Arbeitsgemeinschaft Ethnologie und Medizin